市場調查報告書

蛋白酶K的全球市場:各治療領域,不同形態,各地區的市場規模,佔有率及趨勢分析,各市場區隔預測(2020年∼2027年)

Proteinase K Market Size, Share & Trends Analysis Report By Therapeutic Area (Neurology, Oncology, Infectious Diseases), By Form (Powder, Liquid), By Region, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 968623
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
蛋白酶K的全球市場:各治療領域,不同形態,各地區的市場規模,佔有率及趨勢分析,各市場區隔預測(2020年∼2027年) Proteinase K Market Size, Share & Trends Analysis Report By Therapeutic Area (Neurology, Oncology, Infectious Diseases), By Form (Powder, Liquid), By Region, And Segment Forecasts, 2020 - 2027
出版日期: 2020年10月15日內容資訊: 英文 120 Pages
簡介

全球蛋白酶K的市場規模,從2020年2027年的預測期間內預計將以,7.6%的年複合成長率擴大,到2027年達到1億1,043萬美元。蛋白酶K是一種絲氨酸蛋白酶,通常用於核酸消化過程中的蛋白質消化和污染物去除。這種酶可以使核酸酶失活,從而可以在核酸純化和分離過程中降解RNA或DNA。

本報告提供全球蛋白酶K市場相關調查分析,提供市場及產業預測,各市場區隔·各地區的預測,加上競爭情形相關的系統性資訊。

目錄

第1章 調查方法

第2章 摘要整理

第3章 市場變數,趨勢,範圍

  • 市場趨勢與展望
  • 市場細分化和範圍
  • 市場系統預測
  • 價格分析
  • COVID-19的影響
  • 商務環境分析
  • 市場滲透與治療領域的成長預測的製圖,2019年(百萬美元)

第4章 市場動態

  • 市場成長要素分析
  • 市場抑制因素分析
  • 市場機會分析
  • 市場課題分析

第5章 蛋白酶K市場:各治療領域市場估計·趨勢分析

  • 蛋白酶K市場:各治療領域市場趨勢分析
  • 感染疾病
  • 糖尿病
  • 腫瘤學
  • 心臟病
  • 腎臟學
  • 自體免疫疾病
  • 神經學
  • 其他治療領域

第6章 蛋白酶K市場:不同形態市場估計·趨勢分析

  • 蛋白酶K市場:不同形態市場趨勢分析
  • 粉末
  • 液體

第7章 蛋白酶K市場:各地區市場的估計·趨勢分析

  • 蛋白酶K市場:各地區市場趨勢分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
  • 南美
    • 巴西
    • 墨西哥
  • 中東·非洲(MEA)
    • 南非

第8章 競爭情形

  • 策略架構
  • 參與市場企業的分類
  • 企業簡介
    • Merck KGaA
    • Codexis
    • F. Hoffmann-La Roche Ltd.
    • Amano Enzyme
    • Advanced Enzymes Technologies Ltd.
    • Biocatalysts Ltd.
    • Amicogen
    • Dyadic International
    • BBI Solutions
    • Affymetrix
    • American Laboratories
目錄
Product Code: GVR-4-68039-172-8

Proteinase K Market Growth & Trends

The global proteinase K market is expected to reach USD 110.43 million by 2027, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 7.6% during the forecast period. Proteinase K is a serine protease commonly applied in the digestion of proteins and the removal of contaminants during nucleic acid preparations. The enzyme can deactivate nucleases that can degrade RNA or DNA during the purification and isolation of nucleic acids.

Proteinase K also finds applications in pre-hybridization processing during in situ hybridization. It works by surrounding and digesting the target DNA protein which increases the probability of binding of probes to the target nucleic acid. This ultimately helps in the improvement of the hybridization signal.

However, an increase in the enzyme's concentration leads to a subsequent rise in the digestion time. This could lead to damage to the cell structure, shedding of tissue sections, and disappearance of the nucleus as observed during incubation at high temperature. These factors affect the result of hybridization. Therefore, the initial Proteinase K concentration is checked before its use in diagnostic procedures.

Pretreatment with Proteinase K removes the requirement for performing the entire standard protocol for purification and extraction of a COVID-19 sample. The technique has also proved to be efficient and the results produced are as per the standard RT-qPCR method for COVID-19 diagnosis.

North America dominated the overall market in 2019. A well-regulated IVD market coupled with increasing application of molecular IVD techniques is anticipated to positively impact the market growth. Moreover, the local presence of key players that offer diagnostic enzymes is expected to provide growth opportunities to the market. For instance, Creative Enzymes offers a wide range of enzymes that can be used in diagnostics as well as research purposes.

Proteinase K Market Report Highlights

  • The infectious disease segment held the largest market share in 2019. The wide adoption of the enzyme in COVID-19 diagnostics is expected to maintain contribute to the dominant share of the segment throughout the forecast period
  • The oncology segment also holds a promising market share in 2019 as the proteinase K enzyme is useful for the analysis of cancer specimens. The enzyme has been used to enhance the extraction of RNA from thyroid fine-needle aspiration biopsy specimens and papillary cancer-derived K1 cells
  • The neurology segment is expected to expand at the fastest CAGR from 2020 to 2027. The wide adoption of proteinase K for the detection of Multiple System Atrophy (MSA), Parkinson's disease, Bovine Spongiform Encephalopathy (BSE) proteins, and other prison-related diseases is attributive for the segment growth
  • Liquid proteinase K is projected to register the highest CAGR throughout the analysis period. Commonly, the liquid formulation of the enzyme is highly resistant to the effects of detergents and chelating agents. The liquid proteinase K is nonspecific in its degrading effects and is very rigorous. Merck KGaA and Carolina Biological Supply Company offer commercial-grade liquid proteases
  • Diagnostic and therapeutic grade enzymes require a high degree of specificity and purity. Therefore, the local manufactures have enhanced their manufacturing and R&D capabilities to provide the highest grade of products
  • The key players in the market are involved in novel product launches, acquisition, collaborations, partnerships, and geographical expansions to reinforce their market presence

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Information or Data Analysis
  • 1.3 Market Model
    • 1.3.1 Parent Market Study
      • 1.3.1.1 Global Enzymes Market
      • 1.3.1.2 Global IVD Market
      • 1.3.1.3 Market Study, By Region
  • 1.4 Objectives
    • 1.4.1 OBJECTIVE 1:
    • 1.4.2 OBJECTIVE 2:

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights
  • 2.4 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Trends and Outlook
  • 3.2 Market Segmentation and Scope
  • 3.3 Market Lineage Outlook
    • 3.3.1 Parent Market Analysis
      • 3.3.1.1 IVD Market
      • 3.3.1.2 Molecular Biology Enzymes And Kits Market
      • 3.3.1.3 IVD Enzymes Market
      • 3.3.1.4 Proteases Market
  • 3.4 Pricing Analysis
    • 3.4.1 Pricing and cost considerations
    • 3.4.2 Pricing for Proteinase K: Bulk Order
    • 3.4.3 Pricing for IVD-grade Proteinase K: General Orders
    • 3.4.4 Pricing for Molecular-grade Proteinase K: General Orders
  • 3.5 Impact of COVID-19
    • 3.5.1 Total Number of COVID-19 Tests: Proteinase K, Global (Absolute Number)
  • 3.6 Business Environment Analysis
    • 3.6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
    • 3.6.2 Porter's Five Forces Analysis
  • 3.7 Penetration and Growth Prospect Mapping for Therapeutic Area, 2019 (USD Million)

Chapter 4 Market Dynamics

  • 4.1 Market driver analysis
    • 4.1.1 Broad applications of molecular diagnostic techniques and their associated enzymes for IVD
    • 4.1.2 Rise in demand for point of care diagnostics coupled with the utility of proteinase K in POC diagnostic tests
    • 4.1.3 Rising incidence of chronic disorders
  • 4.2 Market Restraint Analysis
    • 4.2.1 Reimbursement challenges associated with diagnostic tests
  • 4.3 Market Opportunity Analysis
    • 4.3.1 Applications in molecular biology and other fields
  • 4.4 Market Challenge Analysis
    • 4.4.1 Challenges associated with purification & recovery of enzymes

Chapter 5 Proteinase K Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1 Proteinase K Market: Therapeutic Area Movement Analysis
  • 5.2 Infectious Diseases
    • 5.2.1 Proteinase K market for infectious diseases, 2016 - 2027 (USD Million)
  • 5.3 Diabetes
    • 5.3.1 Proteinase K market for diabetes, 2016 - 2027 (USD Million)
  • 5.4 Oncology
    • 5.4.1 Proteinase K market for oncology, 2016 - 2027 (USD Million)
  • 5.5 Cardiology
    • 5.5.1 Proteinase K market for cardiology, 2016 - 2027 (USD Million)
  • 5.6 Nephrology
    • 5.6.1 Proteinase K market for nephrology, 2016 - 2027 (USD Million)
  • 5.7 Autoimmune Diseases
    • 5.7.1 Proteinase K market for autoimmune diseases, 2016 - 2027 (USD Million)
  • 5.8 Neurology
    • 5.8.1 Proteinase K market for neurology, 2016 - 2027 (USD Million)
  • 5.9 Other therapeutic areas
    • 5.9.1 Proteinase K market for other therapeutic areas, 2016 - 2027 (USD Million)

Chapter 6 Proteinase K Market: Form Estimates & Trend Analysis

  • 6.1 Proteinase K Market: Form Movement Analysis
  • 6.2 Powder
    • 6.2.1 Powdered proteinase K market, 2016 - 2027 (USD Million)
  • 6.3 Liquid
    • 6.3.1 Liquid proteinase K market, 2016 - 2027 (USD Million)

Chapter 7 Proteinase K Market: Regional Estimates & Trend Analysis

  • 7.1 Proteinase K Market: Regional Movement Analysis
  • 7.2 North America
    • 7.2.1 North America proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
      • 7.2.2.2 U.S. proteinase K market estimates and forecast, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.2.2.3 U.S. proteinase K market estimates and forecast, by form, 2016 - 2027 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
      • 7.2.3.2 Canada proteinase K market estimates and forecast, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.2.3.3 Canada proteinase K market estimates and forecast, by form, 2016 - 2027 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.3.2 Germany
      • 7.3.2.1 Germany proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
      • 7.3.2.2 Germany proteinase K market estimates and forecast, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.3.2.3 Germany proteinase K market estimates and forecast, by form, 2016 - 2027 (USD Million)
    • 7.3.3 France
      • 7.3.3.1 France proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
      • 7.3.3.2 France proteinase K market estimates and forecast, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.3.3.3 France proteinase K market estimates and forecast, by form, 2016 - 2027 (USD Million)
    • 7.3.4 U.K.
      • 7.3.4.1 U.K. proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
      • 7.3.4.2 U.K. proteinase K market estimates and forecast, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.3.4.3 U.K. proteinase K market estimates and forecast, by form, 2016 - 2027 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Italy proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
      • 7.3.5.2 Italy proteinase K market estimates and forecast, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.3.5.3 Italy proteinase K market estimates and forecast, by form, 2016 - 2027 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Spain proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
      • 7.3.6.2 Spain proteinase K market estimates and forecast, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.3.6.3 Spain proteinase K market estimates and forecast, by form, 2016 - 2027 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
      • 7.4.2.2 Japan proteinase K market estimates and forecast, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.4.2.3 Japan proteinase K market estimates and forecast, by form, 2016 - 2027 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
      • 7.4.3.2 China proteinase K market estimates and forecast, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.4.3.3 China proteinase K market estimates and forecast, by form, 2016 - 2027 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 India proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
      • 7.4.4.2 India proteinase K market estimates and forecast, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.4.4.3 India proteinase K market estimates and forecast, by form, 2016 - 2027 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
      • 7.5.2.2 Brazil proteinase K market estimates and forecast, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.5.2.3 Brazil proteinase K market estimates and forecast, by form, 2016 - 2027 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
      • 7.5.3.2 Mexico proteinase K market estimates and forecast, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.5.3.3 Mexico proteinase K market estimates and forecast, by form, 2016 - 2027 (USD Million)
  • 7.6 Middle East & Africa (MEA)
    • 7.6.1 MEA proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
      • 7.6.2.2 South Africa proteinase K market estimates and forecast, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.6.2.3 South Africa proteinase K market estimates and forecast, by form, 2016 - 2027 (USD Million)

Chapter 8 COMPETITIVE LANDSCAPE

  • 8.1 Strategy Framework
  • 8.2 Market Participation Categorization
  • 8.3 Company Profiles
    • 8.3.1 Merck KGaA
      • 8.3.1.1 Company overview
      • 8.3.1.2 Sigma-Aldrich Co. LLC
      • 8.3.1.2.1 Company overview
      • 8.3.1.3 Financial performance
      • 8.3.1.4 Product benchmarking
      • 8.3.1.5 Strategic initiatives
    • 8.3.2 Codexis
      • 8.3.2.1 Company overview
      • 8.3.2.2 Financial performance
      • 8.3.2.3 Product benchmarking
      • 8.3.2.4 Strategic initiatives
    • 8.3.3 F. Hoffmann-La Roche Ltd.
      • 8.3.3.1 Company overview
      • 8.3.3.2 Financial performance
      • 8.3.3.3 Product benchmarking
      • 8.3.3.4 Strategic initiatives
    • 8.3.4 Amano Enzymes
      • 8.3.4.1 Company overview
      • 8.3.4.2 Financial performance
      • 8.3.4.3 Product benchmarking
      • 8.3.4.4 Strategic initiatives
    • 8.3.5 Advanced Enzymes Technologies Ltd.
      • 8.3.5.1 Company overview
      • 8.3.5.2 Financial performance
      • 8.3.5.3 Product benchmarking
      • 8.3.5.4 Strategic initiatives
    • 8.3.6 Biocatalysts Ltd.
      • 8.3.6.1 Company overview
      • 8.3.6.2 Financial performance
      • 8.3.6.3 Product benchmarking
      • 8.3.6.4 Strategic initiatives
    • 8.3.7 Amicogen
      • 8.3.7.1 Company overview
      • 8.3.7.2 Financial performance
      • 8.3.7.3 Product benchmarking
      • 8.3.7.4 Strategic initiatives
    • 8.3.8 Dyadic International
      • 8.3.8.1 Company overview
      • 8.3.8.2 Financial performance
      • 8.3.8.3 Product benchmarking
      • 8.3.8.4 Strategic initiatives
    • 8.3.9 BBI Solutions
      • 8.3.9.1 Company overview
      • 8.3.9.2 Financial performance
      • 8.3.9.3 Product benchmarking
      • 8.3.9.4 Strategic initiatives
    • 8.3.10 Affymetrix
      • 8.3.10.1 Company overview
      • 8.3.10.2 Financial performance
      • 8.3.10.3 Product benchmarking
      • 8.3.10.4 Strategic initiatives
    • 8.3.11 American Laboratories
      • 8.3.11.1 Company overview
      • 8.3.11.2 Financial performance
      • 8.3.11.3 Product benchmarking
      • 8.3.11.4 Strategic initiatives

List of Tables

  • Table 1 Pricing for Proteinase K: Bulk Order (U.S.)
  • Table 2 Pricing for Proteinase K: Bulk Order (Spain)
  • Table 3 Pricing for Diagnostics Grade Proteinase K: Bulk Order (China)
  • Table 4 Pricing for Proteinase K: Bulk Order (China)
  • Table 5 Pricing for IVD-grade Proteinase K: General Orders (U.S.)
  • Table 6 Pricing for IVD-grade Proteinase K: General Orders (Canada)
  • Table 7 Pricing for IVD-grade Proteinase K: General Orders (Germany)
  • Table 8 Pricing for IVD-grade Proteinase K: General Orders (France)
  • Table 9 Pricing for IVD-grade Proteinase K: General Orders (U.K.)
  • Table 10 Pricing for IVD-grade Proteinase K: General Orders (China)
  • Table 11 Pricing for IVD-grade Proteinase K: General Orders (Japan)
  • Table 12 Pricing for IVD-grade Proteinase K: General Orders (India)
  • Table 13 Pricing for IVD-grade Proteinase K: General Orders (Brazil)
  • Table 14 Pricing for IVD-grade Proteinase K: General Orders (South Africa)
  • Table 15 Pricing for Molecular-grade Proteinase K: General Orders (5mg/ml)
  • Table 16 Pricing for Molecular-grade Proteinase K: General Orders (≥10 mg/mL)
  • Table 17 Pricing for Molecular-grade Proteinase K: General Orders (20mg/ml)
  • Table 18 Manufacturers introducing Proteinase K products for COVID-19
  • Table 19 Comparison of the cycle threshold (CT) of the standard procedure and Proteinase K pretreatment for COVID-19 diagnosis
  • Table 20 Comparison of the HBV DNA yield from different methods
  • Table 21 North America proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 22 North America proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 23 U.S. proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 24 U.S. proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 25 Canada proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 26 Canada proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 27 Europe proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 28 Europe proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 29 Germany proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 30 Germany proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 31 France proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 32 France proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 33 U.K. proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 34 U.K. proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 35 Italy proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 36 Italy proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 37 Spain proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 38 Spain proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 39 Asia Pacific proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 40 Asia Pacific proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 41 Japan proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 42 Japan proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 43 China proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 44 China proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 45 India proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 46 India proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 47 Latin America proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 48 Latin America proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 49 Brazil proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 50 Brazil proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 51 Mexico proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 52 Mexico proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 53 MEA proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 54 MEA proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)
  • Table 55 South Africa proteinase K market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 56 South Africa proteinase K market estimates & forecasts, by form, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation and validation
  • Fig. 8 Market model for proteinase K market derived from enzymes market
  • Fig. 9 Penetration of diagnostic enzymes in the global specialty enzymes market
  • Fig. 10 Market model for proteinase K market derived from the IVD market
  • Fig. 11 Enzyme demand, by region
  • Fig. 12 Enzyme suppliers, by country
  • Fig. 13 Market snapshot (USD Million for 2019)
  • Fig. 14 Market trends & outlook
  • Fig. 15 Oncology companion diagnostics market
  • Fig. 16 Price shift from 5ml to 250 ml of Proteinase K across regions (USD)
  • Fig. 17 Pricing trend for Proteinase K across regions
  • Fig. 18 Pricing variation for IVD grade Proteinase K in key countries (average price, USD)
  • Fig. 19 Total Number of COVID-19 Tests: Proteinase K (Absolute Number)
  • Fig. 20 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 21 Porter's Five Forces Analysis
  • Fig. 22 Penetration and growth prospect mapping for the therapeutic area, 2019 (USD Million)
  • Fig. 23 proteinase K market drivers impact
  • Fig. 24 Proteinase K market restraints impact
  • Fig. 25 Proteinase K market opportunity impact
  • Fig. 26 proteinase K market challenge impact
  • Fig. 27 Proteinase K market: Therapeutic area outlook and key takeaways
  • Fig. 28 Proteinase K market: Therapeutic area movement analysis
  • Fig. 29 Global proteinase K market for infectious diseases, 2016 - 2027 (USD million)
  • Fig. 30 Global proteinase K market for diabetes, 2016 - 2027 (USD million)
  • Fig. 31 Global proteinase K market for oncology, 2016 - 2027 (USD million)
  • Fig. 32 Global proteinase K market for cardiology, 2016 - 2027 (USD million)
  • Fig. 33 Global proteinase K market for nephrology, 2016 - 2027 (USD million)
  • Fig. 34 Global proteinase K market for autoimmune diseases, 2016 - 2027 (USD million)
  • Fig. 35 Global proteinase K market for neurology, 2016 - 2027 (USD million)
  • Fig. 36 Global proteinase K market for other therapeutic areas, 2016 - 2027 (USD million)
  • Fig. 37 Proteinase K market: Form outlook and key takeaways
  • Fig. 38 Proteinase K market: Form movement analysis
  • Fig. 39 Global powdered proteinase K market, 2016 - 2027 (USD million)
  • Fig. 40 Global liquid proteinase K market, 2016 - 2027 (USD million)
  • Fig. 41 Proteinase K market: Regional outlook and key takeaways
  • Fig. 42 Proteinase K market: Regional movement analysis
  • Fig. 43 North America
  • Fig. 44 North America proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 45 U.S.
  • Fig. 46 U.S. proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 47 Canada
  • Fig. 48 Canada proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 49 Europe
  • Fig. 50 Europe proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 51 Germany
  • Fig. 52 Germany proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 53 France
  • Fig. 54 France proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 55 U.K.
  • Fig. 56 U.K. proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 57 Italy
  • Fig. 58 Italy proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 59 Spain
  • Fig. 60 Spain proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 61 Asia Pacific
  • Fig. 62 Asia Pacific proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 63 Japan
  • Fig. 64 Japan proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 65 China
  • Fig. 66 China proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 67 India
  • Fig. 68 India proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 69 Latin America
  • Fig. 70 Latin America proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 71 Brazil
  • Fig. 72 Brazil proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 73 Mexico
  • Fig. 74 Mexico proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 75 MEA
  • Fig. 76 MEA proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 77 South Africa
  • Fig. 78 South Africa proteinase K market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 79 Strategy framework
  • Fig. 80 Market participation categorization